Empiric therapy | 2011 (Baseline) | 2012 (Intervention) | Odds ratio (95 % CI) | P value |
---|---|---|---|---|
Solely Cefazolin or Cloxacillin | 14/102 (13.7 %) | 3/96 (3.1 %) | 0.20 (0.06–0.73) | 0.01 |
Solely Vancomycin | 32/102 (31.4 %) | 36/96 (37.5 %) | 1.31 (0.73–2.36) | 0.36 |
Vancomycin + Cefazolin/Cloxacillin | 14/102 (13.7 %) | 22/96 (22.9 %) | 1.87 (0.89–3.91) | 0.09 |
Vancomycin + other beta-lactam | 30/102 (29.4 %) | 24/96 (25 %) | 0.80 (0.43–1.50) | 0.49 |
No therapy | 2/102 (2.0 %) | 0/96 | 0.98 (0.96–1.01) | 0.17 |
Other empiric therapy | 10/102 (9.8 %) | 11/96 (11.5 %) | 1.19 (0.48–2.45) | 0.71 |